Vaxart Earnings Calls

Sep 30, 2025
-$0.0400 (42.86%)
Release date Nov 13, 2025
EPS estimate -$0.0700
EPS actual -$0.0400
EPS Surprise 42.86%
Revenue estimate 69.7M
Revenue actual 72.413M
Revenue Surprise 3.89%
Jun 30, 2025
-$0.0700 (22.22%)
Release date Aug 13, 2025
EPS estimate -$0.0900
EPS actual -$0.0700
EPS Surprise 22.22%
Revenue estimate 2.2M
Revenue actual 39.73M
Revenue Surprise 1,705.91%
Mar 31, 2025
Release date May 13, 2025
EPS estimate -$0.0700
EPS actual -$0.0700
Revenue estimate 2.85M
Revenue actual 20.876M
Revenue Surprise 632.49%
Dec 31, 2024
-$0.0500 (50.00%)
Release date Mar 20, 2025
EPS estimate -$0.100
EPS actual -$0.0500
EPS Surprise 50.00%
Revenue estimate 20.767M
Revenue actual 15.185M
Revenue Surprise -26.88%

Last 4 Quarters for Vaxart

Below you can see how VXRT performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Dec 31, 2024 Beat
Release date Mar 20, 2025
Price on release $0.568
EPS estimate -$0.100
EPS actual -$0.0500
EPS surprise 50.00%
Date Price
Mar 14, 2025 $0.539
Mar 17, 2025 $0.575
Mar 18, 2025 $0.570
Mar 19, 2025 $0.584
Mar 20, 2025 $0.568
Mar 21, 2025 $0.516
Mar 24, 2025 $0.513
Mar 25, 2025 $0.481
Mar 26, 2025 $0.465
4 days before 5.31%
4 days after -18.18%
On release day -9.09%
Change in period -13.84%
Mar 31, 2025
Release date May 13, 2025
Price on release $0.416
EPS estimate -$0.0700
EPS actual -$0.0700
Date Price
May 07, 2025 $0.389
May 08, 2025 $0.407
May 09, 2025 $0.420
May 12, 2025 $0.405
May 13, 2025 $0.416
May 14, 2025 $0.400
May 15, 2025 $0.425
May 16, 2025 $0.505
May 19, 2025 $0.500
4 days before 6.89%
4 days after 20.29%
On release day -3.73%
Change in period 28.58%
Jun 30, 2025 Beat
Release date Aug 13, 2025
Price on release $0.370
EPS estimate -$0.0900
EPS actual -$0.0700
EPS surprise 22.22%
Date Price
Aug 07, 2025 $0.393
Aug 08, 2025 $0.398
Aug 11, 2025 $0.362
Aug 12, 2025 $0.380
Aug 13, 2025 $0.370
Aug 14, 2025 $0.360
Aug 15, 2025 $0.360
Aug 18, 2025 $0.370
Aug 19, 2025 $0.355
4 days before -5.76%
4 days after -4.05%
On release day -2.70%
Change in period -9.58%
Sep 30, 2025 Beat
Release date Nov 13, 2025
Price on release $0.365
EPS estimate -$0.0700
EPS actual -$0.0400
EPS surprise 42.86%
Date Price
Nov 07, 2025 $0.410
Nov 10, 2025 $0.399
Nov 11, 2025 $0.375
Nov 12, 2025 $0.367
Nov 13, 2025 $0.365
Nov 14, 2025 $0.381
Nov 17, 2025 $0.370
4 days before -10.98%
4 days after 1.40%
On release day 4.38%
Change in period -9.73%

Vaxart Earnings History

Earnings Calendar

FAQ

When is the earnings report for VXRT?
Vaxart (VXRT) has scheduled its earnings report for Mar 19, 2026 after the markets close.

What is the VXRT price-to-earnings (P/E) ratio?
VXRT P/E ratio as of Nov 17, 2025 (TTM) is -1.83.

What is the VXRT EPS forecast?
The forecasted EPS (Earnings Per Share) for Vaxart (VXRT) for the first fiscal quarter 2025 is -$0.0600.

What are Vaxart's retained earnings?
On its balance sheet, Vaxart reported retained earnings of $72.41 million for the latest quarter ending Sep 30, 2025.

What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.

Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.

What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
Click to get the best stock tips daily for free!
ABOUT VAXART
Vaxart
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1 and GII.4 norovirus strains; seasonal influenza vaccine, which is in Phase II clinical trial for the t...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE